M&T Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

M&T Bank’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,218	Closed	-$512K	–	1809
2015 Q2	$512K	Sell	12,218 -1,110	-8%	-$43K	﹤0.01%	1195
2015 Q1	$435K	Sell	13,328 -695	-5%	-$23.9K	﹤0.01%	1261
2014 Q4	$446K	Sell	14,023 -3,450	-20%	-$97.8K	﹤0.01%	1272
2014 Q3	$432K	Buy	+17,473	New	+$409K	﹤0.01%	1338
2014 Q2	–	Sell	-63	Closed	-$2K	–	1078
2014 Q1	$2K	Buy	+63	New	+$1.59K	﹤0.01%	1114

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

M&T Bank's ACAD Position: Q3 2015 in Review

M&T Bank sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 12,218 shares — an estimated $512K sold.

M&T Bank first reported a position in ACAD in Q1 2014 and held it in 5 quarters. The position peaked at $512K in Q2 2015. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

M&T Bank reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
M&T Bank sold 12,218 Acadia Pharmaceuticals shares in Q3 2015, an estimated $512K.
M&T Bank first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 5 quarters.
M&T Bank's Acadia Pharmaceuticals position peaked at $512K in Q2 2015.
188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.